NASDAQ:BIOL   Biolase, Inc.
Idea only not professional advice

BIOLASE Reports 70% Revenue Growth In First Quarter 2021; Continued High Demand From New Users For Dental Lasers.
2021 First Quarter Operating Highlights (all comparisons are on a year over year basis):

Net revenue grew 70% to $8.1 million with:

Laser system sales increased 139%

Consumables and other revenue increased 52%

U.S. revenue increased 67%

International revenue increased 75%

The gross margin was 34%, up 500 basis points

Maintained a strong balance sheet, as cash and cash equivalents totaled $40.8 million on March 31, 2021, up from $17.6 million on December 31, 2020.

Good reports combined with volume entry, the direction seems to be up
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.